Table 8.
Molecular genetic analysis of MMR mutation negative tumours [16].
| __ | MMR Mutation Negative Tumours | % |
|---|---|---|
| MSS | 52 out of 52 | 100% |
| APC mutation | 10 out of 52 | 19.2% |
| Nuclear beta-catenin | 16 out of 44 | 36% |
| Membranous beta-catenin | 28 out of 44 | 63% |
| APC mutation | 9 out of 16 (of tumours with nuclear beta-catenin) |
56% (of tumours with nuclear beta-catenin) |